Skip to content
The 2022 midterms are officially behind us – so, what happened, and what does biotech need to know going into the new year? We […]
2022 midterms recap: what happened and what the results mean for biotech Read More »
The 2023 appropriations legislation currently under debate in Congress should require the U.S. Food and Drug Administration (FDA) to clarify its policy on genome
Spending bill should require FDA to clarify genome editing policy, lawmakers say Read More »
In a development hailed as a possible cancer breakthrough, Moderna announced Tuesday that its experimental personalized cancer vaccine, employing the mRNA technology the company developed
Moderna’s personalized mRNA melanoma vaccine achieves positive results Read More »
When nurse Sandra Lindsay received the first dose of the COVID-19 vaccine in the United States outside of a clinical trial on this day
COVID-19 vaccines two years later: 3 million lives and a trillion dollars saved Read More »
It is time for the Senate to confirm two officials tasked with protecting America’s interests in agricultural trade, says a coalition of agriculture groups
BIO urges Senate to confirm agricultural trade officials Read More »
The lack of gender and racial diversity in medical R&D in the United States is ever-present and persistent, including in trials for COVID-19 medicines
Data shows persistent inequities in U.S. COVID treatment trials, rare disease R&D Read More »
Common bacterial infections are becoming increasingly resistant to antibiotics, “causing life-threatening bloodstream infections,” a new World Health Organization (WHO) report warns. Based on “data
WHO report warns of the rise in antibiotic resistance, seeks better data Read More »
Ahead of a key meeting between the U.S. and Mexico later this week, bipartisan U.S. House Ways & Means Committee members are calling for
Mexico’s treatment of biotech corn needs urgent action, U.S. lawmakers say Read More »
Takeda announced the European Commission (EC) authorized the company’s new dengue vaccine for people aged 4 and up. The European Union approved the two-dose
Takeda’s dengue vaccine approved for use in the EU Read More »
Could the Office of the U.S. Trade Representative’s (USTR) position on the COVID IP waiver be shifting? On December 6, USTR announced support for “extending
U.S. punts decision on COVID IP waiver to 2023 Read More »
